Kent Thoelke is the Chief Scientific Officer and Executive Vice President of PRA Health Sciences. With over 28 years in the drug development and clinical trials industry, Mr. Thoelke has had the opportunity to participate in all levels of drug research from the bench to the bedside globally. Having had the opportunity to work in biotech, pharma and the CRO industries, he brings a unique perspective based on those experiences to the modernization of clinical trials. In addition to his current roles in the oversight of Scientific Affairs, Medical Affairs and Patient Safety, he has spent the last decade focused on the use of Real World Data and Technology to support novel mechanisms to make clinical trial access and drug development more efficient. Through the creation of departments focused solely on Real World Data, Real World Evidence, advanced analytics via machine learning and artificial intelligence, and technology applications to support mobile and virtual trials he has been an industry pioneer, leader and vocal champion for disrupting the current paradigms to ensure that every patient has access to the best possible care options.